[HTML][HTML] Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor

MK Kaneko, Y Kato, A Kameyama, H Ito, A Kuno… - FEBS letters, 2007 - Elsevier
MK Kaneko, Y Kato, A Kameyama, H Ito, A Kuno, J Hirabayashi, T Kubota, K Amano…
FEBS letters, 2007Elsevier
Podoplanin (Aggrus) is a mucin-type sialoglycoprotein that plays a key role in tumor cell-
induced platelet aggregation. Podoplanin possesses a platelet aggregation-stimulating
(PLAG) domain, and Thr52 in the PLAG domain of human podoplanin is important for its
activity. Endogenous or recombinant human podoplanin were purified, and total
glycosylation profiles were surveyed by lectin microarray. Analyses of glycopeptides
produced by Edman degradation and mass spectrometry revealed that the disialyl-corel …
Podoplanin (Aggrus) is a mucin-type sialoglycoprotein that plays a key role in tumor cell-induced platelet aggregation. Podoplanin possesses a platelet aggregation-stimulating (PLAG) domain, and Thr52 in the PLAG domain of human podoplanin is important for its activity. Endogenous or recombinant human podoplanin were purified, and total glycosylation profiles were surveyed by lectin microarray. Analyses of glycopeptides produced by Edman degradation and mass spectrometry revealed that the disialyl-corel (NeuAcα2-3Galβl-3(NeuAcα2-6)GalNAcαl-O-Thr) structure was primarily attached to a glycosylation site at residue Thr52. Sialic acid-deficient podoplanin recovered its activity after additional sialylation. These results indicated that the sialylated Corel at Thr52 is critical for podoplanin-induced platelet aggregation.
Elsevier